APA-referens

Saleem, F. (2017). Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus. Cureus.

Chicago-stil citat

Saleem, Fatima. "Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus." Cureus 2017.

MLA-referens

Saleem, Fatima. "Dapagliflozin: Cardiovascular Safety and Benefits in Type 2 Diabetes Mellitus." Cureus 2017.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.